OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection
Anastasia A. Aksyuk, Himanshu Bansal, Deidre Wilkins, et al.
Cell Reports Medicine (2022) Vol. 4, Iss. 1, pp. 100882-100882
Open Access | Times Cited: 18
Anastasia A. Aksyuk, Himanshu Bansal, Deidre Wilkins, et al.
Cell Reports Medicine (2022) Vol. 4, Iss. 1, pp. 100882-100882
Open Access | Times Cited: 18
Showing 18 citing articles:
Tracking the COVID-19 vaccines: The global landscape
Tushar Yadav, Swatantra Kumar, Gourav Mishra, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 48
Tushar Yadav, Swatantra Kumar, Gourav Mishra, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 48
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza
Man Xing, Gaowei Hu, Xiang Wang, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Man Xing, Gaowei Hu, Xiang Wang, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Inhalable hybrid nanovaccines with virus-biomimetic structure boost protective immune responses against SARS-CoV-2 variants
Shuqi Wang, Peiyang Ding, Lingli Shen, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Shuqi Wang, Peiyang Ding, Lingli Shen, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated
Jill Maaske, Stephanie Sproule, Ann R. Falsey, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 11
Jill Maaske, Stephanie Sproule, Ann R. Falsey, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 11
Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy
Jennifer Serwanga, Claire Baine, Susan Mugaba, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Jennifer Serwanga, Claire Baine, Susan Mugaba, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Transcutaneous vagus nerve stimulation has no anti-inflammatory effect in diabetes
Tina Okdahl, Huda Kufaishi, Ditte Smed Kornum, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Tina Okdahl, Huda Kufaishi, Ditte Smed Kornum, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunity
Ninaad Lasrado, Marjorie Rowe, Katherine McMahan, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 770
Open Access | Times Cited: 2
Ninaad Lasrado, Marjorie Rowe, Katherine McMahan, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 770
Open Access | Times Cited: 2
COVID-19 Vaccines for Optimizing Immunity in the Upper Respiratory Tract
Ranjan Ramasamy
Viruses (2023) Vol. 15, Iss. 11, pp. 2203-2203
Open Access | Times Cited: 6
Ranjan Ramasamy
Viruses (2023) Vol. 15, Iss. 11, pp. 2203-2203
Open Access | Times Cited: 6
Lung mucosal immunity to NTHi vaccine antigens: Antibodies in sputum of chronic obstructive pulmonary disease patients
Federica Baffetta, Cecilia Buonsanti, Luca Moraschini, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Federica Baffetta, Cecilia Buonsanti, Luca Moraschini, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Antibody Dependent Enhancement (ADE) of Infection into Macrophages Validates the Importance of HERV-K102 Particle Production for Pandemic Preparedness
Marian P. Laderoute
(2024)
Open Access | Times Cited: 1
Marian P. Laderoute
(2024)
Open Access | Times Cited: 1
Targeting MAIT cells as a cellular adjuvant for humoral immunity: a new player in a very old game
Nicholas M. Provine
Immunology and Cell Biology (2023) Vol. 101, Iss. 6, pp. 470-472
Open Access | Times Cited: 2
Nicholas M. Provine
Immunology and Cell Biology (2023) Vol. 101, Iss. 6, pp. 470-472
Open Access | Times Cited: 2
COVID-19 Vaccines for Optimizing Immunity in the Upper Respiratory Tract
Ranjan Ramasamy
(2023)
Open Access | Times Cited: 2
Ranjan Ramasamy
(2023)
Open Access | Times Cited: 2
Airway and Systemic Immune Responses Following the Third COVID-19 Vaccination in COPD Patients
Thomas Southworth, Natalie Jackson, Dave Singh
International Journal of COPD (2023) Vol. Volume 18, pp. 3027-3036
Open Access | Times Cited: 2
Thomas Southworth, Natalie Jackson, Dave Singh
International Journal of COPD (2023) Vol. Volume 18, pp. 3027-3036
Open Access | Times Cited: 2
SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters
Ming-Shu Hsieh, Chia-Wei Hsu, HungâChun Liao, et al.
Journal of Virology (2024) Vol. 98, Iss. 2
Open Access
Ming-Shu Hsieh, Chia-Wei Hsu, HungâChun Liao, et al.
Journal of Virology (2024) Vol. 98, Iss. 2
Open Access
Seasonal human coronavirus humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity
Ann Marie Stanley, Anastasia A. Aksyuk, Deidre Wilkins, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Ann Marie Stanley, Anastasia A. Aksyuk, Deidre Wilkins, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study
Kathryn Shoemaker, Karina Soboleva, Angela R. Branche, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 883-883
Open Access
Kathryn Shoemaker, Karina Soboleva, Angela R. Branche, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 883-883
Open Access
Mucosal antibody responses following Vaxzevria vaccination
Kevin J. Selva, Pradhipa Ramanathan, Ebene R. Haycroft, et al.
Immunology and Cell Biology (2023) Vol. 101, Iss. 10, pp. 975-983
Open Access | Times Cited: 1
Kevin J. Selva, Pradhipa Ramanathan, Ebene R. Haycroft, et al.
Immunology and Cell Biology (2023) Vol. 101, Iss. 10, pp. 975-983
Open Access | Times Cited: 1
Antibody Dependent Enhancement (ADE) of Infection into Macrophages Validates the Importance of HERV-K102 Particle Production for Pandemic Preparedness
Marian P. Laderoute
(2023)
Open Access | Times Cited: 1
Marian P. Laderoute
(2023)
Open Access | Times Cited: 1
